ArticleCureus2026
Borderline Myxoid Adrenocortical Neoplasm: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myxoid adrenocortical neoplasm (MAN) is an exceptionally rare variant of adrenal tumor arising from the cortex, with limited cases reported globally. A minor proportion of these are classified as having borderline malignant potential (BMAN). Typically, these neoplasms exhibit a biphasic histological pattern, with both myxoid and conventional non-myxoid regions. Their identification remains challenging, particularly when the myxoid component predominates. The presence of extensive myxoid stroma can obscure traditional histological criteria crucial for malignancy assessment, such as those outlined in the Weiss criteria, thus complicating risk stratification. We report the case of a 34-year-old female patient who presented to the outpatient clinic with a three-month history of persistent headaches, episodic hypertension, and fatigue. Her blood pressure fluctuated between 140-200 and 90-110 mmHg. Imaging revealed an incidental adrenal mass. No significant past medical history or family history of hypertension or cardiovascular disease was reported. The patient subsequently underwent a posterior retroperitoneoscopic adrenalectomy of the left adrenal gland. Histopathological analysis revealed a tumor with prominent myxoid features and a low Weiss score (2), without evidence of capsular or periadrenal invasion, confirming the diagnosis of BMAN. The rarity and distinct histomorphological features of BMANs complicate their diagnosis. This case contributes to the limited literature and underscores the diagnostic challenges involved. The inclusion of these tumors in the differential diagnosis of adrenal masses, particularly when related hormonal abnormalities are present, as well as thorough clinical and histopathological evaluation, is crucial. The favorable outcome of the patient highlights the significance of early diagnosis and complete surgical excision. However, further research is essential for understanding the biological behavior of these neoplasms and for refining the diagnostic criteria and management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.